<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="18/04/2006" creator="Noriko Katsu" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7510691">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>7510691</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">The <cons sem="(AND DNA_domain_or_region DNA_domain_or_region)" id="T1" lex="(AND interleukin-8_AP-1_site kappa_B-like_site)"><frag id="F1"><term sem="DNA_domain_or_region" id="A29">interleukin-8</term> <term sem="DNA_domain_or_region" id="A30">AP-1</term></frag> and <frag id="F2"><term sem="DNA_domain_or_region" id="A31">kappa B-like</term></frag> <frag id="F3"><term sem="DNA_domain_or_region" id="A32">sites</term></frag></cons> are genetic end targets of <term sem="Other" id="T2" lex="FK506-sensitive_pathway"><term sem="Organic_compound_other" id="A11">FK506</term>-sensitive pathway</term> accompanied by <term sem="Other" id="T3" lex="calcium_mobilization"><term sem="Element" id="T4" lex="calcium">calcium</term> mobilization</term>.</sentence>
<event id="E1">
<type class="Localization" />
<theme idref="T4" />
<clue>The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium <clueType>mobilization</clueType>.</clue>
</event>
<event id="E55">
<type class="Correlation" />
<theme idref="E1" />
<theme idref="T2" />
<clue>The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway <clueType>accompanied</clueType> <linkTheme>by</linkTheme> calcium mobilization.</clue>
</event>
<event id="E56">
<type class="Regulation" />
<theme idref1="A30" idref2="A32" idref="A29" />
<cause idref="A11" />
<clue>The interleukin-8 AP-1 and kappa B-like sites are genetic end <clueType>targets</clueType> of FK506<linkCause>-sensitive</linkCause> pathway accompanied by calcium mobilization.</clue>
<comment>SENSITIVITY</comment>
</event>
<event id="E22">
<type class="Regulation" />
<theme idref1="A31" idref2="A32" idref="A29" />
<cause idref="A11" />
<clue>The interleukin-8 AP-1 and kappa B-like sites are genetic end <clueType>targets</clueType> of FK506<linkCause>-sensitive</linkCause> pathway accompanied by calcium mobilization.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="Organic_compound_other" id="T5" lex="FK506">FK506</term>, an <term sem="Other" id="T6" lex="immunosuppressant">immunosuppressant</term>, inhibits the production of several <term sem="Protein_family_or_group" id="T7" lex="cytokine">cytokines</term> in <term sem="Cell_natural" id="T8" lex="T_lymphocyte">T lymphocytes</term>.</sentence>
<event id="E2">
<type class="Gene_expression" />
<theme idref="T7" />
<clue>FK506, an <corefCause>immunosuppressant</corefCause>, inhibits the <clueType>production</clueType> <linkTheme>of</linkTheme> several cytokines <clueLoc>in T lymphocytes</clueLoc>.</clue>
</event>
<event id="E3">
<type class="Negative_regulation" />
<theme idref="E2" />
<cause idref="T5" />
<clue>FK506, an immunosuppressant, <clueType>inhibits</clueType> the production of several cytokines in T lymphocytes.</clue>
</event>
<sentence id="S3">We observed that <term sem="Organic_compound_other" id="T9" lex="FK506">FK506</term> suppressed the transcription of a <term sem="Protein_family_or_group" id="T10" lex="chemotactic_cytokine">chemotactic cytokine</term>, <term sem="Protein_molecule" id="T11" lex="interleukin-8">interleukin-8</term> (<term sem="Protein_molecule" id="T12" lex="IL-8"><term sem="DNA_domain_or_region" id="A13">IL-8</term></term>) in a <term sem="Cell_cultured" id="T13" lex="human_T_cell_line">human T cell line</term>, <term sem="Cell_cultured" id="T14" lex="Jurkat_cell">Jurkat cells</term>, activated by <term sem="Organic_compound_other" id="T15" lex="phorbol_12-myristate_13-acetate">phorbol 12-myristate 13-acetate</term> (<term sem="Organic_compound_other" id="T16" lex="PMA">PMA</term>) and <term sem="Organic_compound_other" id="T17" lex="calcium_(Ca2+)_ionophore"><term sem="Element" id="T18" lex="calcium">calcium</term> (<term sem="Element" id="T19" lex="Ca2+">Ca2+</term>) ionophore</term> (<term sem="Organic_compound_other" id="T20" lex="ionomycin">ionomycin</term>).</sentence>
<event id="E4">
<type class="Transcription" />
<theme idref="A13" />
<clue>We observed that FK506 suppressed the <clueType>transcription</clueType> <linkTheme>of</linkTheme> a <corefTheme>chemotactic cytokine</corefTheme>, interleukin-8 (IL-8) in a human T cell line, Jurkat cells, activated by phorbol 12-myristate 13-acetate (PMA) and calcium (Ca2+) ionophore (ionomycin).</clue>
</event>
<event id="E5">
<type class="Positive_regulation" />
<theme idref="T14" />
<cause idref="T16" />
<cause idref="T20" />
<clue>We observed that FK506 suppressed the transcription of a chemotactic cytokine, interleukin-8 (IL-8) in a <corefTheme>human T cell line</corefTheme>, Jurkat cells, <clueType>activated</clueType> <linkCause>by</linkCause> phorbol 12-myristate 13-acetate (PMA) and calcium (Ca2+) ionophore (ionomycin).</clue>
</event>
<event id="E7">
<type class="Negative_regulation" />
<theme idref="E4" />
<cause idref="T9" />
<clue>We observed that FK506 <clueType>suppressed</clueType> the transcription of a chemotactic cytokine, interleukin-8 (IL-8) <clueLoc>in a human T cell line, Jurkat cells, activated by phorbol 12-myristate 13-acetate (PMA) and calcium (Ca2+) ionophore (ionomycin)</clueLoc>.</clue>
</event>
<sentence id="S4">By deleted and mutated analysis of the <term sem="DNA_domain_or_region" id="T21" lex="IL-8_promoter"><term sem="Protein_molecule" id="T22" lex="IL-8">IL-8</term> promoters</term>, the <term sem="DNA_domain_or_region" id="T23" lex="AP-1_and_kappa_B-like_site"><term sem="DNA_domain_or_region" id="T24" lex="AP-1_site">AP-1</term> and <term sem="DNA_domain_or_region" id="T25" lex="kappa_B-like_site">kappa B-like <term sem="DNA_domain_or_region" id="A20">sites</term></term></term> were identified as the responsive elements for <term sem="Organic_compound_other" id="T26" lex="PMA">PMA</term> and <term sem="Organic_compound_other" id="T27" lex="ionomycin">ionomycin</term>.</sentence>
<event id="E9">
<type class="Regulation" />
<theme idref1="A20" idref="T24" />
<cause idref="T26" />
<clue><clueExperiment>By deleted and mutated analysis of the IL-8 promoters</clueExperiment>, the AP-1 and kappa B-like sites were identified as the <clueType>responsive</clueType> elements <linkCause>for</linkCause> PMA and ionomycin.</clue>
</event>
<event id="E10">
<type class="Regulation" />
<theme idref1="A20" idref="T24" />
<cause idref="T27" />
<clue><clueExperiment>By deleted and mutated analysis of the IL-8 promoters</clueExperiment>, the AP-1 and kappa B-like sites were identified as the <clueType>responsive</clueType> elements <linkCause>for</linkCause> PMA and ionomycin.</clue>
</event>
<event id="E11">
<type class="Regulation" />
<theme idref="T25" />
<cause idref="T26" />
<clue><clueExperiment>By deleted and mutated analysis of the IL-8 promoters</clueExperiment>, the AP-1 and kappa B-like sites were identified as the <clueType>responsive</clueType> elements <linkCause>for</linkCause> PMA and ionomycin.</clue>
</event>
<event id="E12">
<type class="Regulation" />
<theme idref="T25" />
<cause idref="T27" />
<clue><clueExperiment>By deleted and mutated analysis of the IL-8 promoters</clueExperiment>, the AP-1 and kappa B-like sites were identified as the <clueType>responsive</clueType> elements <linkCause>for</linkCause> PMA and ionomycin.</clue>
</event>
<event id="E13">
<type class="Mutagenesis" />
<theme idref="T21" />
<clue>By <clueType>deleted</clueType> and mutated analysis <linkTheme>of</linkTheme> the IL-8 promoters, the AP-1 and kappa B-like sites were identified as the responsive elements for PMA and ionomycin.</clue>
<comment>ARTIFICIAL</comment>
</event>
<event id="E14">
<type class="Mutagenesis" />
<theme idref="T21" />
<clue>By deleted and <clueType>mutated</clueType> analysis <linkTheme>of</linkTheme> the IL-8 promoters, the AP-1 and kappa B-like sites were identified as the responsive elements for PMA and ionomycin.</clue>
<comment>ARTIFICIAL</comment>
</event>
<sentence id="S5"><term sem="Organic_compound_other" id="T28" lex="FK506">FK506</term> suppressed the <term sem="Other" id="A14">transcriptions</term> through the <term sem="DNA_domain_or_region" id="T29" lex="AP-1_site">AP-1</term> or <term sem="DNA_domain_or_region" id="T30" lex="kappa_B-like_site">kappa B-like <term sem="DNA_domain_or_region" id="A21">sites</term></term> induced by <term sem="Organic_compound_other" id="T31" lex="PMA">PMA</term> plus <term sem="Organic_compound_other" id="A1">Ca(2+)-mobilizing agents</term>, but not those induced by <term sem="Other" id="A2">Ca(2+)-independent stimuli</term>.</sentence>
<event id="E15">
<type class="Positive_regulation" />
<theme idref="E4" />
<cause idref="T29" />
<clue>FK506 suppressed <corefTheme>the transcriptions</corefTheme> <linkCause>through</linkCause> the AP-1 or kappa B-like sites induced by PMA plus Ca(2+)-mobilizing agents, but not those induced by Ca(2+)-independent stimuli.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E16">
<type class="Positive_regulation" />
<theme idref="E4" />
<cause idref="T30" />
<clue>FK506 suppressed <corefTheme>the transcriptions</corefTheme> <linkCause>through</linkCause> the AP-1 or kappa B-like sites induced by PMA plus Ca(2+)-mobilizing agents, but not those induced by Ca(2+)-independent stimuli.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E17">
<type class="Positive_regulation" />
<theme idref="E15" />
<cause idref="T31" />
<cause idref="A1" />
<clue>FK506 suppressed the transcriptions through the AP-1 or kappa B-like sites <clueType>induced</clueType> <linkCause>by</linkCause> PMA plus Ca(2+)-mobilizing agents, but not those induced by Ca(2+)-independent stimuli.</clue>
</event>
<event id="E18">
<type class="Positive_regulation" />
<theme idref="E16" />
<cause idref="T31" />
<cause idref="A1" />
<clue>FK506 suppressed the transcriptions through the AP-1 or kappa B-like sites <clueType>induced</clueType> <linkCause>by</linkCause> PMA plus Ca(2+)-mobilizing agents, but not those induced by Ca(2+)-independent stimuli.</clue>
</event>
<event id="E23">
<type class="Negative_regulation" />
<theme idref="E17" />
<cause idref="T28" />
<clue>FK506 <clueType>suppressed</clueType> the transcriptions through the AP-1 or kappa B-like sites induced by PMA plus Ca(2+)-mobilizing agents, but not those induced by Ca(2+)-independent stimuli.</clue>
</event>
<event id="E24">
<type class="Negative_regulation" />
<theme idref="E18" />
<cause idref="T28" />
<clue>FK506 <clueType>suppressed</clueType> the transcriptions through the AP-1 or kappa B-like sites induced by PMA plus Ca(2+)-mobilizing agents, but not those induced by Ca(2+)-independent stimuli.</clue>
</event>
<event id="E27">
<type class="Positive_regulation" />
<theme idref="E15" />
<cause idref="A2" />
<clue>FK506 suppressed the transcriptions through the AP-1 or kappa B-like sites induced by PMA plus Ca(2+)-mobilizing agents, but not <corefTheme>those</corefTheme> <clueType>induced</clueType> <linkCause>by</linkCause> Ca(2+)-independent stimuli.</clue>
</event>
<event id="E28">
<type class="Positive_regulation" />
<theme idref="E16" />
<cause idref="A2" />
<clue>FK506 suppressed the transcriptions through the AP-1 or kappa B-like sites induced by PMA plus Ca(2+)-mobilizing agents, but not <corefTheme>those</corefTheme> <clueType>induced</clueType> <linkCause>by</linkCause> Ca(2+)-independent stimuli.</clue>
</event>
<event assertion="non-exist" id="E31">
<type class="Negative_regulation" />
<theme idref="E27" />
<cause idref="T28" />
<clue>FK506 <clueType>suppressed</clueType> the transcriptions through the AP-1 or kappa B-like sites induced by PMA plus Ca(2+)-mobilizing agents, but not those induced by Ca(2+)-independent stimuli.</clue>
</event>
<event assertion="non-exist" id="E32">
<type class="Negative_regulation" />
<theme idref="E28" />
<cause idref="T28" />
<clue>FK506 <clueType>suppressed</clueType> the transcriptions through the AP-1 or kappa B-like sites induced by PMA plus Ca(2+)-mobilizing agents, but not those induced by Ca(2+)-independent stimuli.</clue>
</event>
<sentence id="S6">In gel retardation analysis, <term sem="Organic_compound_other" id="T32" lex="FK506">FK506</term> had little effect on the binding to the <term sem="DNA_domain_or_region" id="T33" lex="AP-1_site">AP-1 site</term> of <term sem="Organic_compound_other" id="T34" lex="PMA">PMA</term>/<term sem="Organic_compound_other" id="T35" lex="ionomycin">ionomycin</term>-induced <term sem="Protein_family_or_group" id="A3">nuclear factors</term>, which were recognized with <term sem="Protein_family_or_group" id="T36" lex="anti-JunD"><term sem="Protein_family_or_group" id="A4">anti-</term><term sem="Protein_family_or_group" id="A5">Jun</term>D</term> or <term sem="Protein_family_or_group" id="T37" lex="c-Fos_antibody"><term sem="Protein_family_or_group" id="A6">c-Fos</term> <term sem="Protein_family_or_group" id="A7">antibody</term></term>.</sentence>
<event id="E35">
<type class="Positive_regulation" />
<theme idref="A3" />
<cause idref="T34" />
<cause idref="T35" />
<clue>In gel retardation analysis, FK506 had little effect on the binding to the AP-1 site of PMA/ionomycin-<clueType>induced</clueType> nuclear factors, which were recognized with anti-JunD or c-Fos antibody.</clue>
</event>
<event id="E36">
<type class="Binding" />
<theme idref="T33" />
<theme idref="A3" />
<clue>In gel retardation analysis, FK506 had little effect on the <clueType>binding</clueType> <linkTheme>to</linkTheme> the AP-1 site <linkTheme>of</linkTheme> PMA/ionomycin-induced nuclear factors, which were recognized with anti-JunD or c-Fos antibody.</clue>
</event>
<event id="E37">
<type class="Binding" />
<theme idref1="A5" idref2="A7" idref="A4" />
<theme idref="A3" />
<clue>In gel retardation analysis, FK506 had little effect on the binding to the AP-1 site of PMA/ionomycin-induced nuclear factors, which were <clueType>recognized</clueType> <linkTheme>with</linkTheme> anti-JunD or c-Fos antibody.</clue>
</event>
<event id="E38">
<type class="Binding" />
<theme idref1="A5" idref2="A7" idref="A4" />
<theme idref="A3" />
<clue>In gel retardation analysis, FK506 had little effect on the binding to the AP-1 site of PMA/ionomycin-induced nuclear factors, which were <clueType>recognized</clueType> <linkTheme>with</linkTheme> anti-JunD or c-Fos antibody.</clue>
</event>
<event assertion="non-exist" id="E39">
<type class="Regulation" />
<theme idref="E36" />
<cause idref="T32" />
<clue><clueExperiment>In gel retardation analysis</clueExperiment>, FK506 had little <clueType>effect</clueType> <linkTheme>on</linkTheme> the binding to the AP-1 site of PMA/ionomycin-induced nuclear factors, which were recognized with anti-JunD or c-Fos antibody.</clue>
</event>
<sentence id="S7">In contrast, <term sem="Organic_compound_other" id="T38" lex="FK506">FK506</term> or <term sem="Organic_compound_other" id="T39" lex="EGTA">EGTA</term> (<term sem="Other" id="T40" lex="Ca2+_chelator"><term sem="Element" id="T41" lex="Ca2+">Ca2+</term> chelator</term>) similarly affected the formation of <term sem="Protein_complex" id="T42" lex="kappa_B-like_site_binding_complex">kappa B-like site binding complexes</term>, which were not recognized by any <term sem="Protein_family_or_group" id="A8"><term sem="Protein_family_or_group" id="T43" lex="antibody">antibodies</term> against</term> the <term sem="Protein_family_or_group" id="T44" lex="human_Rel_family_protein">human Rel family proteins</term> (<term sem="Protein_molecule" id="T45" lex="c-Rel">c-Rel</term>, <term sem="Protein_molecule" id="T46" lex="p65">p65</term>, <term sem="Protein_molecule" id="T47" lex="p50">p50</term>, and <term sem="Protein_molecule" id="T48" lex="p49">p49</term>).</sentence>
<event id="E19">
<type class="Regulation" />
<theme idref="E40" />
<cause idref="T38" />
<clue>In contrast, FK506 or EGTA (Ca2+ chelator) similarly <clueType>affected</clueType> the formation of kappa B-like site binding complexes, which were not recognized by any antibodies against the human Rel family proteins (c-Rel, p65, p50, and p49).</clue>
</event>
<event id="E20">
<type class="Regulation" />
<theme idref="E40" />
<cause idref="T39" />
<clue>In contrast, FK506 or EGTA (<corefCause>Ca2+ chelator</corefCause>) similarly <clueType>affected</clueType> the formation of kappa B-like site binding complexes, which were not recognized by any antibodies against the human Rel family proteins (c-Rel, p65, p50, and p49).</clue>
</event>
<event id="E40">
<type class="Protein_metabolism" />
<theme idref="T42" />
<clue>In contrast, FK506 or EGTA (Ca2+ chelator) similarly affected the <clueType>formation</clueType> <linkTheme>of</linkTheme> kappa B-like site binding complexes, which were not recognized by any antibodies against the human Rel family proteins (c-Rel, p65, p50, and p49).</clue>
</event>
<event assertion="non-exist" id="E41">
<type class="Binding" />
<theme idref="T42" />
<theme idref1="T45" idref="A8" />
<clue>In contrast, FK506 or EGTA (Ca2+ chelator) similarly affected the formation of kappa B-like site binding complexes, which were not <clueType>recognized</clueType> <linkTheme>by</linkTheme> any antibodies against the human Rel family proteins (c-Rel, p65, p50, and p49).</clue>
<comment>TPS: A8</comment>
</event>
<event assertion="non-exist" id="E42">
<type class="Binding" />
<theme idref="T42" />
<theme idref1="T46" idref="A8" />
<clue>In contrast, FK506 or EGTA (Ca2+ chelator) similarly affected the formation of kappa B-like site binding complexes, which were not <clueType>recognized</clueType> <linkTheme>by</linkTheme> any antibodies against the human Rel family proteins (c-Rel, p65, p50, and p49).</clue>
<comment>TPS: A8</comment>
</event>
<event assertion="non-exist" id="E43">
<type class="Binding" />
<theme idref="T42" />
<theme idref1="T47" idref="A8" />
<clue>In contrast, FK506 or EGTA (Ca2+ chelator) similarly affected the formation of kappa B-like site binding complexes, which were not <clueType>recognized</clueType> <linkTheme>by</linkTheme> any antibodies against the human Rel family proteins (c-Rel, p65, p50, and p49).</clue>
<comment>TPS: A8</comment>
</event>
<event assertion="non-exist" id="E44">
<type class="Binding" />
<theme idref="T42" />
<theme idref1="T48" idref="A8" />
<clue>In contrast, FK506 or EGTA (Ca2+ chelator) similarly affected the formation of kappa B-like site binding complexes, which were not <clueType>recognized</clueType> <linkTheme>by</linkTheme> any antibodies against the human Rel family proteins (c-Rel, p65, p50, and p49).</clue>
<comment>TPS: A8</comment>
</event>
<sentence id="S8">Furthermore, we confirmed the previous report that <term sem="Organic_compound_other" id="T49" lex="FK506">FK506</term> suppressed the <term sem="Organic_compound_other" id="T50" lex="PMA">PMA</term>/<term sem="Organic_compound_other" id="T51" lex="ionomycin">ionomycin</term>-induced activation through authentic <term sem="DNA_domain_or_region" id="A24"><term sem="DNA_domain_or_region" id="T52" lex="kappa_B_site">kappa B site</term> of <term sem="DNA_domain_or_region" id="T53" lex="immunoglobulin_(Ig)_gene">immunoglobulin (Ig) gene</term></term>, to which <term sem="Other" id="T54" lex="NF-kappa_B_binding"><term sem="Protein_molecule" id="T55" lex="NF-kappa_B">NF-kappa B</term> binding</term> was also decreased by <term sem="Organic_compound_other" id="T56" lex="FK506">FK506</term>, indicating that both <term sem="DNA_domain_or_region" id="T57" lex="IL-8_kappa_B-like_site"><term sem="Protein_molecule" id="T58" lex="IL-8">IL-8</term> kappa B-like site</term> and <term sem="DNA_domain_or_region" id="A9">Ig <term sem="DNA_domain_or_region" id="T59" lex="kappa_B_site">kappa B site</term></term> are <term sem="Other" id="T60" lex="FK506-sensitive"><term sem="Organic_compound_other" id="T61" lex="FK506">FK506</term>-sensitive</term> in spite of the difference of <term sem="Protein_family_or_group" id="T62" lex="binding_factor">binding factors</term>.</sentence>
<event id="E45">
<type class="Positive_regulation" />
<theme idref="T53" />
<cause idref="T50" />
<cause idref="T51" />
<clue>Furthermore, we confirmed the previous report that FK506 suppressed the PMA/ionomycin<linkCause>-induced</linkCause> <clueType>activation</clueType> through authentic kappa B site <linkTheme>of</linkTheme> immunoglobulin (Ig) gene, to which NF-kappa B binding was also decreased by FK506, indicating that both IL-8 kappa B-like site and Ig kappa B site are FK506-sensitive in spite of the difference of binding factors.</clue>
</event>
<event id="E6">
<type class="Positive_regulation" />
<theme idref="E45" />
<cause idref="A24" />
<clue>Furthermore, we confirmed the previous report that FK506 suppressed the PMA/ionomycin-induced activation <linkCause>through</linkCause> authentic kappa B site of immunoglobulin (Ig) gene, to which NF-kappa B binding was also decreased by FK506, indicating that both IL-8 kappa B-like site and Ig kappa B site are FK506-sensitive in spite of the difference of binding factors.</clue>
<comment>TPS: A24; NO CLUETYPE</comment>
</event>
<event id="E47">
<type class="Negative_regulation" />
<theme idref="E45" />
<cause idref="T46" />
<clue>Furthermore, we confirmed the previous report that FK506 <clueType>suppressed</clueType> the PMA/ionomycin-induced activation through authentic kappa B site of immunoglobulin (Ig) gene, to which NF-kappa B binding was also decreased by FK506, indicating that both IL-8 kappa B-like site and Ig kappa B site are FK506-sensitive in spite of the difference of binding factors.</clue>
</event>
<event id="E48">
<type class="Binding" />
<theme idref="A24" />
<theme idref="T55" />
<clue>Furthermore, we confirmed the previous report that FK506 suppressed the PMA/ionomycin-induced activation through authentic kappa B site of immunoglobulin (Ig) gene, <linkTheme>to</linkTheme> <corefTheme>which</corefTheme> NF-kappa B <clueType>binding</clueType> was also decreased by FK506, indicating that both IL-8 kappa B-like site and Ig kappa B site are FK506-sensitive in spite of the difference of binding factors.</clue>
<comment>TPS: A24</comment>
</event>
<event id="E49">
<type class="Negative_regulation" />
<theme idref="E48" />
<cause idref="T56" />
<clue>Furthermore, we confirmed the previous report that FK506 suppressed the PMA/ionomycin-induced activation through authentic kappa B site of immunoglobulin (Ig) gene, to which NF-kappa B binding was also <clueType>decreased</clueType> <linkCause>by</linkCause> FK506, indicating that both IL-8 kappa B-like site and Ig kappa B site are FK506-sensitive in spite of the difference of binding factors.</clue>
</event>
<event id="E50">
<type class="Regulation" />
<theme idref="T57" />
<cause idref="T61" />
<clue>Furthermore, we confirmed the previous report that FK506 suppressed the PMA/ionomycin-induced activation through authentic kappa B site of immunoglobulin (Ig) gene, to which NF-kappa B binding was also decreased by FK506, indicating that both IL-8 kappa B-like site and Ig kappa B site are FK506-<clueType>sensitive</clueType> in spite of the difference of binding factors.</clue>
<comment>SENSITIVITY</comment>
</event>
<event id="E51">
<type class="Regulation" />
<theme idref="A9" />
<cause idref="T61" />
<clue>Furthermore, we confirmed the previous report that FK506 suppressed the PMA/ionomycin-induced activation through authentic kappa B site of immunoglobulin (Ig) gene, to which NF-kappa B binding was also decreased by FK506, indicating that both IL-8 kappa B-like site and Ig kappa B site are FK506-<clueType>sensitive</clueType> in spite of the difference of binding factors.</clue>
</event>
<sentence id="S9">Our results indicate that not only the reported <cons sem="(AND DNA_domain_or_region DNA_domain_or_region)" id="T63" lex="(AND IL-2_NF-AT_site NFIL-2A_site)"><frag id="F4">IL-2 NF-AT</frag> and <frag id="F5">NFIL-2A</frag> <frag id="F6">sites</frag></cons> and Ig <term sem="DNA_domain_or_region" id="T64" lex="kappa_B_site">kappa B site</term>, but also the <term sem="Protein_molecule" id="T65" lex="IL-8">IL-8</term> <term sem="DNA_domain_or_region" id="T66" lex="AP-1_site">AP-1</term> and <term sem="DNA_domain_or_region" id="T67" lex="kappa_B-like_site">kappa B-like sites</term> are terminals of <term sem="Other" id="T68" lex="FK506-sensitive_pathwa"><term sem="Organic_compound_other" id="T69" lex="FK506">FK506</term>-sensitive <term sem="Other" id="A10">pathway</term></term> involving <term sem="Other" id="T70" lex="Ca2+_mobilization"><term sem="Element" id="T71" lex="Ca2+">Ca2+</term> mobilization</term>.</sentence>
<event id="E52">
<type class="Localization" />
<theme idref="T71" />
<clue>Our results indicate that not only the reported IL-2 NF-AT and NFIL-2A sites and Ig kappa B site, but also the IL-8 AP-1 and kappa B-like sites are terminals of FK506-sensitive pathway involving Ca2+ <clueType>mobilization</clueType>.</clue>
</event>
<event id="E21">
<type class="Correlation" />
<theme idref="T68" />
<theme idref="T70" />
<clue>Our results indicate that not only the reported IL-2 NF-AT and NFIL-2A sites and Ig kappa B site, but also the IL-8 AP-1 and kappa B-like sites are terminals of FK506-sensitive pathway <clueType>involving</clueType> Ca2+ mobilization.</clue>
</event>
<event id="E54">
<type class="Regulation" />
<theme idref="A10" />
<cause idref="T69" />
<clue>Our results indicate that not only the reported IL-2 NF-AT and NFIL-2A sites and Ig kappa B site, but also the IL-8 AP-1 and kappa B-like sites are terminals of FK506-<clueType>sensitive</clueType> pathway involving Ca2+ mobilization.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
